Virtu Financial LLC Takeda Pharmaceutical CO LTD Transaction History

Virtu Financial LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	BUY	$15.57 - $17.11 $189,393 - $208,126	12,164 New	12,164 $191,000
Q3 2022 Nov 07, 2022	BUY	$12.8 - $28.65 $137,203 - $307,099	10,719 New	10,719 $139,000
Q2 2022 Aug 09, 2022	SELL	$13.12 - $15.03 $132,577 - $151,878	-10,105 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$13.54 - $15.35 $13,946 - $15,810	-1,030 Reduced 9.25%	10,105 $145,000
Q4 2021 Feb 17, 2022	SELL	$13.17 - $16.4 $286,078 - $356,240	-21,722 Reduced 66.11%	11,135 $152,000
Q3 2021 Nov 12, 2021	BUY	$16.3 - $17.26 $216,887 - $229,661	13,306 Added 68.06%	32,857 $538,000
Q2 2021 Sep 17, 2021	BUY	$16.55 - $18.64 $33,795 - $38,062	2,042 Added 11.66%	19,551 $329,000
Q1 2021 May 19, 2021	BUY	$16.71 - $19.9 $292,575 - $348,429	17,509 New	17,509 $320,000
Q4 2019 Feb 04, 2020	SELL	$16.88 - $20.83 $194,575 - $240,107	-11,527 Closed	0 $0
Q3 2019 Nov 20, 2019	SELL	$16.15 - $17.99 $8,462 - $9,426	-524 Reduced 4.35%	11,527 $198,000
Q2 2019 Aug 13, 2019	BUY	$16.58 - $20.49 $199,805 - $246,924	12,051 New	12,051 $213,000

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.